What are the therapeutic implications of increased collagen expression in melanoma cells treated with vemurafenib?

Melanoma Manag. 2016 Mar;3(1):5-8. doi: 10.2217/mmt.15.36. Epub 2016 Feb 18.
No abstract available

Keywords: BRAFV600E; BRAFWT; MAPK signaling; MEK inhibitors; TGF-β; carcinoma-activated fibroblasts; fibroblasts; tumor microenvironment; vemurafenib/PLX4032.

Publication types

  • Editorial